Response to SGX Queries::

Issuer & Securities

Issuer/ Manager
SINGAPORE EDEVELOPMENT LIMITED
Securities
SINGAPORE EDEVELOPMENT LTD - SG1AE2000006 - 40V
Stapled Security
No

Announcement Details

Announcement Title
Response to SGX Queries
Date &Time of Broadcast
25-Jun-2020 22:29:14
Status
New
Supplementary Title
On Other Announcements
Others (Please Specify)
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance
Announcement Reference
SG200625OTHRE1JB
Submitted By (Co./ Ind. Name)
Chan Heng Fai
Designation
Executive Chairman and Chief Executive Officer
Description (Please provide a detailed description of the change in the box below)
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance - Response to SGX Queries

Attachments